Published Mar 21, 2026 | 7:00 AM ⚊ Updated Mar 21, 2026 | 7:00 AM
The study, included 132 unmedicated adolescents aged 12 to 17 with moderate to severe irritability.
Synopsis: A broad-spectrum micronutrient supplement may reduce severe irritability in teenagers, reducing emotional reactivity, a new eight-week-long clinical trial has found. The effect was most visible in adolescents with disruptive mood dysregulation disorder, with gains in behaviour and suicidal ideation and only mild side effects. Researchers said the findings are preliminary and need larger studies, while doctors in India said the results are promising but warned against self-prescribing.
Did you know that severe irritability in teenagers—be it frequent flare-ups of anger, emotional outbursts, shouting, or low tolerance for frustration—may be reduced with a daily mix of vitamins and minerals?
A new clinical trial found that adolescents who took a broad-spectrum micronutrient supplement for eight weeks showed greater overall improvement than those given a placebo. The findings draw attention to whether nutrition could play a larger role in mental healthcare.
The study, called the BEAM trial (Balancing Emotions of Adolescents with Micronutrients), found that the benefits were especially notable in adolescents with disruptive mood dysregulation disorder (DMDD), a condition marked by chronic irritability and repeated temper outbursts.
Paediatrician Dr Sivaranjani Santosh, who is not connected to the study, told South First that any deficiency of micronutrients can lead to poor attention, excessive irritability, and a very low threshold for irritation. “It’s a well-known fact,” she added.
Dr Gopikrishna G, a paediatrician from Agrasena Hospital in Bengaluru, concurred.
“Irritability in teens is often brushed aside as a teenage phase. But persistent irritability can be serious and can affect life at home, school, and relationships with parents and friends,” he told South First.
Dr Gopikrishna added that several conditions can trigger these emotions. Children with conditions such as ADHD, anxiety, mood disorders, oppositional defiant disorder, and autism spectrum disorder can behave in a similar manner.
The study, included 132 unmedicated adolescents aged 12 to 17 with moderate to severe irritability. They were randomly split into two groups. One group received a broad-spectrum micronutrient supplement, while the other was given an active placebo.
The trial lasted eight weeks. Neither the participants nor the researchers knew who was receiving the actual supplement, making it a double-blind randomised controlled trial.
The teenagers were monitored remotely through weekly parent and adolescent questionnaires, and monthly online meetings with a registered psychologist. To be eligible, participants had to show clear irritability symptoms.
They also had to stick to the treatment plan, which involved swallowing up to 12 capsules a day. The researchers excluded teenagers already taking psychiatric medicines, and those with certain neurological or metabolic conditions.
The supplement used in the study was not a single vitamin pill. It was a broad formula containing several vitamins and minerals, including vitamin A, vitamin C, vitamin D, vitamin E, vitamin K, and B vitamins such as thiamin, riboflavin, niacin, vitamin B6, folate, and vitamin B12.
It also contained minerals such as magnesium, zinc, iron, calcium, iodine, selenium, copper, manganese, chromium, molybdenum, potassium, and phosphorus. Researchers said that “such nutrients are important for brain development, neurotransmitter function, energy production, and controlling inflammation.”
The researchers called the findings preliminary but promising. Both groups involved in the study improved over time, but the micronutrient group did better on some main outcome measures. Teenagers taking the supplement showed better overall clinical improvement and lower emotional reactivity than those on placebo.
The strongest effect was in adolescents with disruptive mood dysregulation disorder (DMDD), a condition marked by chronic irritability and repeated temper outbursts.
Among teenagers with DMDD, 64.3 percent of those taking micronutrients were considered responders, compared with 12.5 percent in the placebo group. The study also found improvements in symptom severity, conduct problems, prosocial behaviour, and adolescent-reported suicidal ideation.
Researchers also said that teens from lower socioeconomic backgrounds were more likely to respond to the micronutrient treatment. This may matter for future efforts to understand who benefits most from such interventions.
They said broad-spectrum micronutrients may be an effective and safe treatment option for adolescent irritability, especially in young people with DMDD.
They also pointed to a reduction in suicidal ideation.
On safety, the findings were largely reassuring. The only side effect that was more common in the micronutrient group was temporary diarrhoea, reported in 20.9 percent of participants compared with 6.2 percent in the placebo group. Fewer than 10 percent found swallowing the capsules difficult.
Still, they said larger studies are needed before this can be recommended as routine treatment.
Doctors South First spoke to said the study seems promising, but warned parents not to self-prescribe supplements in large doses.
Dr Sanjay G, a paediatrician and physician, said nutrition may play a bigger role in adolescent mental health, but many families do not understand this. He added that the study opens the door to that possibility.
Dr Mahesh Gowda, a psychiatrist from Bengaluru, said irritability in teens is real and clinically important. But treatment usually starts only after careful diagnosis and assessment of comorbidities, family context, psychotherapy, school interventions, and disorder-specific treatment, not supplements alone.
He added that Indian Psychiatric Society guidance for child and adolescent conditions emphasises structured assessment and multimodal management.
For autism-related irritability, for example, it points to behavioural approaches and, when needed, evidence-based medicines such as risperidone or aripiprazole, rather than nutritional formulas as standard care.
(Edited by Dese Gowda)
